1	Heterogeneous	heterogeneous	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
5	virus	virus	_	_	_	_	_	_	_
6	latent	latent	_	_	_	_	_	_	_
7	proteins	protein	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	endemic	endemic	_	_	_	_	_	_	_
10	Burkitt	Burkitt	_	_	_	_	_	_	_
11	’s	's	_	_	_	_	_	_	_
12	lymphoma	lymphoma	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
2	virus	virus	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	EBV)-infected	ebv)-infected	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	may	may	_	_	_	_	_	_	_
7	sustain	sustain	_	_	_	_	_	_	_
8	three	three	_	_	_	_	_	_	_
9	distinct	distinct	_	_	_	_	_	_	_
10	forms	form	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	virus	virus	_	_	_	_	_	_	_
13	latency	latency	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	lymphoblastoid	lymphoblastoid	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	lines	line	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	six	six	_	_	_	_	_	_	_
7	EBV-encoded	ebv-encoded	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	antigens	antigen	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	EBNA1	EBNA1	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	2	2	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	3A	3a	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	3B	3b	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	3C	3c	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	-LP	-LP	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	three	three	_	_	_	_	_	_	_
25	latent	latent	_	_	_	_	_	_	_
26	membrane	membrane	_	_	_	_	_	_	_
27	proteins	protein	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	LMP1	LMP1	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	2A	2a	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	2B	2b	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	two	two	_	_	_	_	_	_	_
38	nuclear	nuclear	_	_	_	_	_	_	_
39	RNAs	rna	_	_	_	_	_	_	_
40	(	(	_	_	_	_	_	_	_
41	EBERs	EBER	_	_	_	_	_	_	_
42	)	)	_	_	_	_	_	_	_
43	are	be	_	_	_	_	_	_	_
44	expressed	express	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	form	form	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	latency	latency	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	termed	term	_	_	_	_	_	_	_
7	latency	latency	_	_	_	_	_	_	_
8	III	iii	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	also	also	_	_	_	_	_	_	_
12	encountered	encounter	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	some	some	_	_	_	_	_	_	_
15	posttransplant	posttransplant	_	_	_	_	_	_	_
16	lymphoproliferative	lymphoproliferative	_	_	_	_	_	_	_
17	disorders	disorder	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	EBV-positive	ebv-positive	_	_	_	_	_	_	_
3	cases	case	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	Hodgkin	Hodgkin	_	_	_	_	_	_	_
6	’s	's	_	_	_	_	_	_	_
7	disease	disease	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	EBERs	EBER	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	EBNA1	EBNA1	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	LMPs	LMP	_	_	_	_	_	_	_
17	are	be	_	_	_	_	_	_	_
18	expressed	express	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	latency	latency	_	_	_	_	_	_	_
21	II	ii	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	whereas	whereas	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	Burkitt	Burkitt	_	_	_	_	_	_	_
27	’s	's	_	_	_	_	_	_	_
28	lymphoma	lymphoma	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	BL	BL	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	only	only	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	EBERs	EBER	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	EBNA1	EBNA1	_	_	_	_	_	_	_
37	have	have	_	_	_	_	_	_	_
38	been	be	_	_	_	_	_	_	_
39	detected	detect	_	_	_	_	_	_	_
40	(	(	_	_	_	_	_	_	_
41	latency	latency	_	_	_	_	_	_	_
42	I	i	_	_	_	_	_	_	_
43	)	)	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	studied	study	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	EBV	EBV	_	_	_	_	_	_	_
8	proteins	protein	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	17	17	_	_	_	_	_	_	_
11	cases	case	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	EBV-positive	ebv-positive	_	_	_	_	_	_	_
14	endemic	endemic	_	_	_	_	_	_	_
15	BL	bl	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	immunohistology	immunohistology	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Expression	expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	LMP1	LMP1	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	seen	see	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	variable	variable	_	_	_	_	_	_	_
8	proportions	proportion	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	tumor	tumor	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	two	two	_	_	_	_	_	_	_
14	cases	case	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	EBNA2	ebna2	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	detected	detect	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	some	some	_	_	_	_	_	_	_
21	tumor	tumor	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	three	three	_	_	_	_	_	_	_
25	other	other	_	_	_	_	_	_	_
26	cases	case	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Also	also	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	BZLF1	bzlf1	_	_	_	_	_	_	_
5	trans-activator	trans-activator	_	_	_	_	_	_	_
6	protein	protein	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	expressed	express	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	few	few	_	_	_	_	_	_	_
12	tumor	tumor	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	6	6	_	_	_	_	_	_	_
16	cases	case	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	indicating	indicate	_	_	_	_	_	_	_
19	entry	entry	_	_	_	_	_	_	_
20	into	into	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	lytic	lytic	_	_	_	_	_	_	_
23	cycle	cycle	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	phenotypic	phenotypic	_	_	_	_	_	_	_
3	drift	drift	_	_	_	_	_	_	_
4	from	from	_	_	_	_	_	_	_
5	latency	latency	_	_	_	_	_	_	_
6	I	i	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	latency	latency	_	_	_	_	_	_	_
9	III	iii	_	_	_	_	_	_	_
10	has	have	_	_	_	_	_	_	_
11	been	be	_	_	_	_	_	_	_
12	observed	observe	_	_	_	_	_	_	_
13	previously	previously	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	some	some	_	_	_	_	_	_	_
16	BL	BL	_	_	_	_	_	_	_
17	cell	cell	_	_	_	_	_	_	_
18	lines	line	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	similar	similar	_	_	_	_	_	_	_
7	phenomenon	phenomenon	_	_	_	_	_	_	_
8	may	may	_	_	_	_	_	_	_
9	occur	occur	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	BL	BL	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	vivo	vivo	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	indicate	indicate	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	operational	operational	_	_	_	_	_	_	_
19	definition	definition	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	EBV	EBV	_	_	_	_	_	_	_
22	latencies	latency	_	_	_	_	_	_	_
23	is	be	_	_	_	_	_	_	_
24	not	not	_	_	_	_	_	_	_
25	easily	easily	_	_	_	_	_	_	_
26	applied	apply	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	human	human	_	_	_	_	_	_	_
29	tumors	tumor	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

